Skip to Main content Skip to Navigation
Journal articles

Suivi après radiothérapie d’un cancer du canal anal

Abstract : Anal canal carcinoma is a rare and curable disease for which the standard of care is radiation therapy with concurrent 5-fluoro-uracil and mitomycine-based chemotherapy. Post-treatment follow-up however is rather poorly defined. This article offers a review of the various post-treatment surveillance options both for early diagnosis of relapse and care for late treatment effects. While follow-up remains mostly clinical, we will discuss morphologic (endorectal echoendoscopy, pelvic magnetic resonance imaging, tomodensitometry and positron emission tomography) and biologic (squamous cell carcinoma antigen and pathology) follow-up so as to determine their diagnostic and prognostic value.
Document type :
Journal articles
Complete list of metadata
Contributor : Apemac Ul Connect in order to contact the contributor
Submitted on : Tuesday, June 12, 2018 - 10:42:50 AM
Last modification on : Thursday, January 27, 2022 - 3:26:15 AM



N. Meillan, F. Huguet, D. Peiffert. Suivi après radiothérapie d’un cancer du canal anal. Cancer Radiothérapie, Elsevier Masson, 2015, 19 (6-7), pp.610 - 615. ⟨10.1016/j.canrad.2015.06.011⟩. ⟨hal-01813231⟩



Record views